Debridement: Controlling the Necrotic/Cellular Burden
Authors:
- Janet E. CuddiganJCJanet E. Cuddigan
- 1 March 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Advances in Skin & Wound Care
- Vol. 17 (2) , 66-75
Abstract
To provide physicians and nurses with an overview of the options for debriding a chronic wound to improve wound healing. This continuing education activity is intended for physicians and nurses with an interest in learning about methods for debriding chronic wounds to promote wound healing. After reading the article and taking the test, the participant will be able to: 1. Describe the 4 types of debridement most commonly used in clinical practice. 2. Describe when to debride a wound and how to determine which method to use.Keywords
This publication has 10 references indexed in Scilit:
- Collagenase Ointment Application at 24- versus 48-hour Intervals in the Treatment of Pressure UlcersClinical Drug Investigation, 2000
- The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen MatrixJournal of Cell Biology, 1997
- Cytotoxicity and Sensitization of Povidone-lodine and Other Frequently Used Anti-Infective AgentsDermatology, 1997
- α1-Antitrypsin Is Degraded and Non-Functional in Chronic Wounds But Intact and Functional in Acute Wounds: The Inhibitor Protects Fibronectin from Degradation by Chronic Wound Fluid EnzymesJournal of Investigative Dermatology, 1995
- Human Keratinocytes Make Uniquely Linear Phagokinetic TracksDermatology, 1994
- Molecular Mechanisms Regulating the Vascular Endothelial Cell Motile Response to InjuryJournal of Cardiovascular Pharmacology, 1993
- Non-toxic antiseptic irrigation with chlorhexidine in experimental revascularization in the ratJournal of Hospital Infection, 1991
- Activation of Keratinocyte Fibronectin Receptor Function During Cutaneous Wound HealingJournal of Cell Science, 1987
- Extracellular matrix-cytoskeletal interactions in vascular cellsTissue and Cell, 1987
- Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides.Proceedings of the National Academy of Sciences, 1978